| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |